InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Monday, 04/08/2019 1:00:40 PM

Monday, April 08, 2019 1:00:40 PM

Post# of 745
News: $BLPH Bellerophon Announces Agreement with FDA on Regulatory Approval Pathway for INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease

FDA Agrees to Primary Endpoint of Change in Moderate to Vigorous Physical Activity from Baseline to Week 16, Measured by Actigraphy FDA Also Agrees on Modification of Ongoing Phase 2b Study into a Phase 2/3 Trial, with Cohort 3 Serving as the Pivotal Phase 3 Study Completion of Co...

In case you are interested https://marketwirenews.com/news-releases/bellerophon-announces-agreement-with-fda-on-regulatory-approval-pathway-for-inopulse-xae-for-treatment-of-pulmonary-hypertension-associated-with-interstitial-lung-disease-7963154.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BLPH News